Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Mar;51(3):399–401. doi: 10.1136/ard.51.3.399

Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy.

S Kobayashi 1, N Tamura 1, H Tsuda 1, C Mokuno 1, H Hashimoto 1, S Hirose 1
PMCID: PMC1004672  PMID: 1575592

Abstract

The case of a 34 year old woman with systemic lupus erythematosus with a history of three previous recurrent abortions and lupus anticoagulant and anticardiolipin antibodies is reported. Immunoadsorbent plasmapheresis with a dextran sulphate column was used to remove lupus anticoagulant, anticardiolipin antibodies, and antibodies to DNA during her fourth pregnancy in combination with low doses of aspirin and prednisolone. Although during the course of treatment prednisolone was transiently increased to 30 mg/day owing to an asymptomatic increase of lupus anticoagulant and anticardiolipin antibodies, the levels of lupus anticoagulant, anticardiolipin antibodies, and antibodies to DNA were decreased by immunoadsorbent plasmapheresis and a baby girl was delivered successfully by caesarean section. Therefore, immunoadsorbent plasmapheresis with dextran sulphate seems to reduce the risk of recurrent abortion in patients with the antiphospholipid syndrome.

Full text

PDF
399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babson A. L., Babson S. R. Comparative evaluation of a partial thromboplastin reagent containing a non-settling, particulate activator. Am J Clin Pathol. 1974 Dec;62(6):856–860. doi: 10.1093/ajcp/62.6.856. [DOI] [PubMed] [Google Scholar]
  2. Branch D. W., Scott J. R., Kochenour N. K., Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 1985 Nov 21;313(21):1322–1326. doi: 10.1056/NEJM198511213132104. [DOI] [PubMed] [Google Scholar]
  3. Buyon J., Roubey R., Swersky S., Pompeo L., Parke A., Baxi L., Winchester R. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol. 1988 Jul;15(7):1104–1108. [PubMed] [Google Scholar]
  4. Byron M. A. The clotting defect in SLE. Clin Rheum Dis. 1982 Apr;8(1):137–151. [PubMed] [Google Scholar]
  5. Carreras L. O., Vermylen J., Spitz B., Van Assche A. "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol. 1981 Sep;88(9):890–894. doi: 10.1111/j.1471-0528.1981.tb02224.x. [DOI] [PubMed] [Google Scholar]
  6. De Wolf F., Carreras L. O., Moerman P., Vermylen J., Van Assche A., Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol. 1982 Apr 1;142(7):829–834. doi: 10.1016/s0002-9378(16)32527-3. [DOI] [PubMed] [Google Scholar]
  7. Exner T., Rickard K. A., Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol. 1978 Sep;40(1):143–151. doi: 10.1111/j.1365-2141.1978.tb03648.x. [DOI] [PubMed] [Google Scholar]
  8. Feinstein D. I. Lupus anticoagulant, thrombosis, and fetal loss. N Engl J Med. 1985 Nov 21;313(21):1348–1350. doi: 10.1056/NEJM198511213132109. [DOI] [PubMed] [Google Scholar]
  9. Harris E. N., Gharavi A. E., Patel S. P., Hughes G. R. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 Apr;68(1):215–222. [PMC free article] [PubMed] [Google Scholar]
  10. Hitomi Y., Ikari N., Fujii S. Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system. Haemostasis. 1985;15(3):164–168. doi: 10.1159/000215139. [DOI] [PubMed] [Google Scholar]
  11. Kinoshita M., Aotsuka S., Funahashi T., Tani N., Yokohari R. Selective removal of anti-double-stranded DNA antibodies by immunoadsorption with dextran sulphate in a patient with systemic lupus erythematosus. Ann Rheum Dis. 1989 Oct;48(10):856–860. doi: 10.1136/ard.48.10.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet. 1983 Jun 18;1(8338):1361–1363. doi: 10.1016/s0140-6736(83)92141-4. [DOI] [PubMed] [Google Scholar]
  13. Lubbe W. F., Liggins G. C. Lupus anticoagulant and pregnancy. Am J Obstet Gynecol. 1985 Oct 1;153(3):322–327. doi: 10.1016/s0002-9378(85)80124-1. [DOI] [PubMed] [Google Scholar]
  14. Nakajima T., Nakamura T., Funahashi T., Kanai H., Kurata Y., Matsuzawa Y., Tarui S. A novel system of LDL apheresis combining a centrifugal plasma separator with a specific LDL adsorption column. Atherosclerosis. 1988 Oct;73(2-3):143–148. doi: 10.1016/0021-9150(88)90035-4. [DOI] [PubMed] [Google Scholar]
  15. Takahashi K., Yoshinoya S., Yoshizawa H., Miyamoto T. Extracorporeal hydrophobic amino acid adsorbent therapy in rheumatoid arthritis. Clin Rheumatol. 1987 Dec;6(4):553–563. doi: 10.1007/BF02330593. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES